Immatics N.V. (IMTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Immatics N.V., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$7.35
+1.24% today
Market cap
$1.1B
Overall quality
—
Kronos AI 30-day
+28.3%
8 of 8 simulated paths end higher
Immatics N.V. (IMTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $1.1B. It trades at $7.35, up 1.24% today. 6 analysts' average target of $17.16 implies +133.5% from today's price. Kronos AI's 30-day forecast is +28.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $17.16 |
| Low – high | $11.80 – $25.00 |
| Analysts | 6 |
| Upside to average | +133.5% |
Kronos AI 30-day forecast
| Expected close | $9.32 (+28.3%) |
| Likely range | +21.0% … +39.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.